Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 277 articles:
HTML format
Text format



Single Articles


    October 2017
  1. ECHEVARRIA MI, Naghavi AO, Abuodeh YA, Ahmed KA, et al
    Low-dose-rate Brachytherapy for Prostate Cancer in Low-resource Settings.
    Int J Radiat Oncol Biol Phys. 2017;99:378-382.
    PubMed     Text format     Abstract available


  2. PINKAWA M, Berneking V, Schlenter M, Krenkel B, et al
    Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results.
    Int J Radiat Oncol Biol Phys. 2017;99:374-377.
    PubMed     Text format     Abstract available


    September 2017
  3. DAYES IS, Parpia S, Gilbert J, Julian JA, et al
    Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.
    Int J Radiat Oncol Biol Phys. 2017;99:90-93.
    PubMed     Text format     Abstract available


    August 2017
  4. MALLA B, Zaugg K, Vassella E, Aebersold DM, et al
    Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:982-995.
    PubMed     Text format     Abstract available


  5. GLASER SM, Chen KS, Benoit RM, Smith RP, et al
    Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131.
    Int J Radiat Oncol Biol Phys. 2017;98:1053-1058.
    PubMed     Text format     Abstract available


  6. WANG C, Kishan AU, Kamrava M, Steinberg ML, et al
    External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Int J Radiat Oncol Biol Phys. 2017;98:1045-1052.
    PubMed     Text format     Abstract available


  7. BEN-JOSEF AM, Chen J, Wileyto P, Doucette A, et al
    Effect of Eischens Yoga During Radiation Therapy on Prostate Cancer Patient Symptoms and Quality of Life: A Randomized Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2017;98:1036-1044.
    PubMed     Text format     Abstract available


    July 2017
  8. FANG P, He W, Gomez DR, Hoffman KE, et al
    Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Int J Radiat Oncol Biol Phys. 2017;98:748-757.
    PubMed     Text format     Abstract available


  9. MIDDELBURG JG, Mast ME, de Kroon M, Jobsen JJ, et al
    Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:843-849.
    PubMed     Text format     Abstract available


  10. SONG YP, Ellis T, Walshaw R, Mbanu P, et al
    Comparing Clinical Outcomes for Radium-223: Do Older Patients Do Worse?
    Int J Radiat Oncol Biol Phys. 2017;98:955-957.
    PubMed     Text format     Abstract available


  11. WAHL DR, Nguyen PL, Santiago M, Yousefi K, et al
    Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
    Int J Radiat Oncol Biol Phys. 2017;98:726-732.
    PubMed     Text format     Abstract available


  12. MOROTE J, Tabernero AJ, Alvarez Ossorio JL, Ciria JP, et al
    Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.
    Int J Radiat Oncol Biol Phys. 2017;98:590-594.
    PubMed     Text format     Abstract available


  13. RODDA S, Morris WJ, Hamm J, Duncan G, et al
    ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:581-589.
    PubMed     Text format     Abstract available


  14. CORKUM MT
    Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
    Int J Radiat Oncol Biol Phys. 2017;98:492-493.
    PubMed     Text format    


    June 2017
  15. DADKHAH H, Hopfensperger KM, Kim Y, Wu X, et al
    Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jun 20. pii: S0360-3016(17)31057.
    PubMed     Text format     Abstract available


  16. SHENG Y, Li T, Lee WR, Yin FF, et al
    Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
    Int J Radiat Oncol Biol Phys. 2017;98:473-480.
    PubMed     Text format     Abstract available


  17. YANG DD, Muralidhar V, Mahal BA, Labe SA, et al
    National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:338-343.
    PubMed     Text format     Abstract available


  18. O'CALLAGHAN ME, Raymond E, Campbell JM, Vincent AD, et al
    Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity.
    Int J Radiat Oncol Biol Phys. 2017;98:318-337.
    PubMed     Text format     Abstract available


  19. LAWTON CAF, Lin X, Hanks GE, Lepor H, et al
    Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.
    Int J Radiat Oncol Biol Phys. 2017;98:296-303.
    PubMed     Text format     Abstract available


  20. SPRATT DE, Jagsi R
    Breast and Prostate Cancer: Lessons to Be Shared.
    Int J Radiat Oncol Biol Phys. 2017;98:263-268.
    PubMed     Text format    


  21. CHARGARI C, Haie-Meder C, Guerin F, Minard-Colin V, et al
    Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2017;98:352-359.
    PubMed     Text format     Abstract available


  22. GAY HA, Sanda MG, Liu J, Wu N, et al
    External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
    Int J Radiat Oncol Biol Phys. 2017;98:304-317.
    PubMed     Text format     Abstract available


    May 2017
  23. HAUCK CR, Ye H, Chen PY, Gustafson GS, et al
    Increasing Fractional Doses Increases the Probability of Benign PSA Bounce in Patients Undergoing Definitive HDR Brachytherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:108-114.
    PubMed     Text format     Abstract available


  24. GESTAUT MM, Cai W, Vyas S, Patel BJ, et al
    Low-Dose-Rate Brachytherapy Versus Cryotherapy in Low- and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:101-107.
    PubMed     Text format     Abstract available


    April 2017
  25. KANOUN S, Walker P, Vrigneaud JM, Depardon E, et al
    18F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional
    Int J Radiat Oncol Biol Phys. 2017;97:986-994.
    PubMed     Text format     Abstract available


  26. CIEZKI JP, Weller M, Reddy CA, Kittel J, et al
    A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk
    Int J Radiat Oncol Biol Phys. 2017;97:962-975.
    PubMed     Text format     Abstract available


  27. YOSHIOKA Y, Kotsuma T, Komiya A, Kariya S, et al
    Nationwide, Multicenter, Retrospective Study on High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:952-961.
    PubMed     Text format     Abstract available


  28. BOSCO C, Garmo H, Adolfsson J, Stattin P, et al
    Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events.
    Int J Radiat Oncol Biol Phys. 2017;97:1026-1031.
    PubMed     Text format     Abstract available


  29. SCHILD MH, Schild SE, Wong WW, Vora SA, et al
    A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT.
    Int J Radiat Oncol Biol Phys. 2017;97:1021-1025.
    PubMed     Text format     Abstract available


  30. REED A, Valle LF, Shankavaram U, Krauze A, et al
    Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.
    Int J Radiat Oncol Biol Phys. 2017;97:947-951.
    PubMed     Text format     Abstract available


  31. HAMSTRA DA, Mariados N, Sylvester J, Shah D, et al
    Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.
    Int J Radiat Oncol Biol Phys. 2017;97:976-985.
    PubMed     Text format     Abstract available


    March 2017
  32. SHAIKH T, Li T, Handorf EA, Johnson ME, et al
    Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:722-731.
    PubMed     Text format     Abstract available


  33. BEKELMAN JE, Lee WR
    Six Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:718-721.
    PubMed     Text format    


  34. SIMON A, Le Maitre A, Nassef M, Rigaud B, et al
    Is Dose Deformation-Invariance Hypothesis Verified in Prostate IGRT?
    Int J Radiat Oncol Biol Phys. 2017;97:830-838.
    PubMed     Text format     Abstract available


  35. NICOLAE A, Morton G, Chung H, Loblaw A, et al
    Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2017;97:822-829.
    PubMed     Text format     Abstract available


  36. SHAVERDIAN N, Verruttipong D, Wang PC, Kishan AU, et al
    Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:516-525.
    PubMed     Text format     Abstract available


  37. MIRHADI AJ, Zhang Q, Hanks GE, Lepor H, et al
    Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.
    Int J Radiat Oncol Biol Phys. 2017;97:511-515.
    PubMed     Text format     Abstract available


  38. HOLCH P, Henry AM, Davidson S, Gilbert A, et al
    Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:495-510.
    PubMed     Text format     Abstract available


  39. MIKSYS N, Vigneault E, Martin AG, Beaulieu L, et al
    Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2017;97:606-615.
    PubMed     Text format     Abstract available


  40. PARKER WP, Evans JD, Stish BJ, Park SS, et al
    Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2017;97:526-535.
    PubMed     Text format     Abstract available


    February 2017
  41. GRIVAS N, Wit E, Pos F, de Jong J, et al
    Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression.
    Int J Radiat Oncol Biol Phys. 2017;97:347-354.
    PubMed     Text format     Abstract available


  42. YAHYA N, Ebert MA, House MJ, Kennedy A, et al
    Modeling Urinary Dysfunction After External Beam Radiation Therapy of the Prostate Using Bladder Dose-Surface Maps: Evidence of Spatially Variable Response of the Bladder Surface.
    Int J Radiat Oncol Biol Phys. 2017;97:420-426.
    PubMed     Text format     Abstract available


  43. MISHRA MV, Aggarwal S, Bentzen SM, Knight N, et al
    Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:228-235.
    PubMed     Text format     Abstract available


    January 2017
  44. RODDA S, Tyldesley S, Morris WJ, Keyes M, et al
    ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jan 6. pii: S0360-3016(17)30008.
    PubMed     Text format     Abstract available


  45. KRAUSS DJ, Ye H, Martinez AA, Mitchell B, et al
    Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2017;97:98-106.
    PubMed     Text format     Abstract available


  46. PINKAWA M
    Zoledronic Acid in First-Line Treatment of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:6-8.
    PubMed     Text format    


    November 2016
  47. MORRIS WJ, Tyldesley S, Rodda S, Halperin R, et al
    Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boo
    Int J Radiat Oncol Biol Phys. 2016 Nov 24. pii: S0360-3016(16)33484.
    PubMed     Text format     Abstract available


  48. ROSE BS, Chen MH, Wu J, Braccioforte MH, et al
    Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality.
    Int J Radiat Oncol Biol Phys. 2016;96:778-784.
    PubMed     Text format     Abstract available


  49. NAIK M, Reddy CA, Stephans KL, Ciezki JP, et al
    Posttreatment Prostate-Specific Antigen 6 Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality.
    Int J Radiat Oncol Biol Phys. 2016;96:617-23.
    PubMed     Text format     Abstract available


    October 2016
  50. NARAYAN V, Vapiwala N, Mick R, Subramanian P, et al
    Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2016 Oct 20. pii: S0360-3016(16)33333.
    PubMed     Text format     Abstract available


  51. ZAPATERO A, Guerrero A, Maldonado X, Alvarez A, et al
    Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96:341-8.
    PubMed     Text format     Abstract available


  52. VAN HEMELRYK A, De Meerleer G, Ost P, Poelaert F, et al
    The Outcome for Patients With Pathologic Node-Positive Prostate Cancer Treated With Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy: A Case-Matched Analysis of pN1 and pN0 Patients.
    Int J Radiat Oncol Biol Phys. 2016;96:323-32.
    PubMed     Text format     Abstract available


  53. GHIAM AF, Taeb S, Huang X, Jahangiri S, et al
    The Biological Role and Clinical Significance of Long Noncoding RNA Urothelial Carcinoma Associated 1 (UCA1) in Prostate Cancer (PCa).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  54. GRECO C, Pares O, Pimentel N, Louro V, et al
    Phase 1/2 Study of Urethral and Rectal Sparing Following Extreme Hypofractionated (5x9 Gy) Stereotactic Body Radiation Therapy in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  55. DESS RT, Jackson WC, Suy S, Lee JY, et al
    Predictors of Multidomain Decline in Health-Related Quality of Life After Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  56. MEIER R, Beckman A, Henning G, Mohideen N, et al
    Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  57. CHEUNG P, Morton G, Szumacher E, Danjoux C, et al
    Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost For Localized High-Risk Prostate Cancer: Five-Year Results of a Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  58. LIENG H, Pintilie M, Berlin A, Bayley A, et al
    Long-Term Outcomes of a Phase 2 Trial of Moderate Hypofractionated Image Guided Intensity Modulated Radiation Therapy (IG-IMRT) for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  59. HOFFMAN KE, Voong KR, Levy LB, Pugh TJ, et al
    Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  60. SPRATT DE, Zhao SG, Chang SL, Cooperberg MR, et al
    Identification and Validation of Intrinsic Subtypes of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  61. KORHONEN J, Visapaa H, Seppala T, Kapanen M, et al
    Clinical Experiences of Treating Prostate Cancer Patients With Magnetic Resonance Imaging-Only Based Radiation Therapy Treatment Planning Workflow.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  62. VAN HERK MB, McWilliam A, Sanderson B, Kennedy J, et al
    Toward a Data Mining Approach for Risk Stratification in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  63. WATKINS BRUNER D, Pugh SL, Lee WR, Dignam JJ, et al
    NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  64. COULTER JB, Haffner MC, Mian OY, Kim K, et al
    Partial Agonist Activity of Hydroxyflutamide Induces AR- and TOP2B-dependent DNA Double Strand Breaks and Radiosensitizes Prostate Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  65. VAPIWALA N, Narayan V, Subramanian P, Christodouleas JP, et al
    Phase I Trial of Everolimus in Combination with Salvage Radiation Therapy (RT) for Post-prostatectomy Biochemical Recurrence (BCR) in Prostate Cancer (PC) Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  66. GHIAM AF, Vesprini D, Taeb S, Jahangiri S, et al
    Serum Exosomal MicroRNAs (miRNAs) as Noninvasive Biomarkers to Guide Postoperative Radiation Therapy in Prostate Cancer (PCa) Patients Treated With Radical Prostatectomy (RP).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  67. KUMAR P, Veldhuizen P, Thompson M, Shen X, et al
    Trimodality Therapy Is Tolerable and Feasible in Patients With Postprostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer: Results of a Phase 1-2 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  68. NABID A, Carrier N, Vigneault E, Souhami L, et al
    Second Malignancies as First Cause of Death in Localized Prostate Cancer Treated With Radiation Therapy: Data from Two Phase 3 Trials.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  69. NOMIYA T, Tsuji H, Kawamura H, Ohno T, et al
    A Multi-institutional Analysis of Prospective Studies of Carbon Ion Radiation Therapy for Prostate Cancer: An Analysis of 2157 Patients from the Japan Carbon Ion Radiation Oncology Study Group (J-CROS).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  70. BYUN J, Goyal S, Kim IY, Parikh RR, et al
    Local Therapy Improves Overall Survival in Patients with Newly Diagnosed Metastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  71. HELOU J, Torres S, Musunuru HB, Cheung P, et al
    Low-Dose-Rate Brachytherapy Versus Standard Fractionated External Beam Radiation Therapy Versus Stereotactic Body Radiation Therapy for Low-Risk Prostate Cancer: A Cost-Utility Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  72. FERO KE, Paravati AJ, Panjwani N, Boero IJ, et al
    The Impact of Radiation Cost on Patient Outcomes After Definitive Radiation Therapy in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  73. LESTER-COLL NH, Johnson S, Magnuson WJ, Yu JB, et al
    Assessing Potential Cardiovascular Risk Against the Benefits of Hormonal Therapy in Men With Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  74. ROSE B, Chen MH, Wu J, Braccioforte MH, et al
    Androgen Deprivation Therapy Use in the Setting of High-Dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  75. ZAPATERO A, Guerrero AD, Maldonado J, Alvarez A, et al
    Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  76. JOHNSON SB, Lester-Coll NH, Kelly JR, Yu JB, et al
    Comparing Overall Survival for Androgen Suppression and Low-Dose-Rate Brachytherapy Boost Versus Androgen Suppression and External Beam Radiation Boost for Men With Unfavorable Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  77. SARGOS P, Mottet N, Molinie V, Richaud PM, et al
    Long-Term Androgen Deprivation, With or Without Radiation Therapy, in Locally Advanced Prostate Cancer: Results From a Phase 3 Randomized Study After 7.3 Years' Median Follow-up.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  78. SCHULER JC, Marshall DT
    Decreasing Utilization of Brachytherapy as a Boost Modality in the Treatment of High-Risk Prostate Cancer: A National Patterns of Care Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  79. HARTSELL WF, Godes D, Ketch TD, Caron J, et al
    Proton Therapy in the USA From 2012 to 2014-Increasing Treatment of Pediatric, Lung, Head and Neck, Gastrointestinal, and Breast Cancers, But No Increase in Prostate Cancer Treatments: A Study From the National Association for Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  80. DOSANI M, Morris J, Tyldesley S, Pickles T, et al
    The Relationship Between Hot Flashes and Testosterone Recovery Following 12 Months of Androgen Suppression for Men With Localized Prostate Cancer in a Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  81. REPKA MC, Kole TP, Wu B, Tong M, et al
    Effect of Dose to the Bladder Wall and Trigone on Late Urinary Flare Following Definitive Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  82. CHUA ML, Salcedo A, Meng A, Zhang J, et al
    Genomic Architecture of Prostate Cancer at Recurrence Following Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  83. SO J, Chua ML, Lalonde E, Pra AD, et al
    Prognostic Significance of Tonsil Expression and the Homologous Recombination Pathway in Intermediate-Risk Prostate Cancer Recurrence.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  84. NGUYEN PL, Martin NE, Palmer-Aronsten BJ, Choeurng V, et al
    The Use of a Biopsy-Based Genomic Classifier to Predict the Risk of Distant Metastasis After Definitive Radiation and Short-Course Androgen Deprivation Therapy for Intermediate- and High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  85. BACH-GANSMO T, Nanni C, Nieh P, Zanoni L, et al
    Staging of Biochemically Relapsing Prostate Cancer Using the Positron Emission Tomography Tracer Fluciclovine F18.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  86. PARKER WP, Davis BJ, Park SS, Olivier K, et al
    Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  87. AMIT U, Goldstein JD, Davidson T, Hahiashvili M, et al
    The Role of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography in the Management of Patients With Prostate Cancer: Implications for Selection of Patients for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  88. SHEN C, Minn I, Chen Y, Mease RC, et al
    Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen in a Micrometastatic Model of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  89. BELZ J, Ojo NC, Kumar R, Cormack RA, et al
    Docetaxel-Loaded Brachytherapy Spacers for Combined Chemoradiation Therapy in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  90. ZHAO SG, Chang SL, Spratt DE, Erho NG, et al
    A 24-Gene Predictor of Response to Postoperative Radiation Therapy in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  91. WONG AT, Schwartz D, Osborn V, Safdieh J, et al
    Adjuvant Radiation With Hormonal Therapy Is Associated With Improved Survival for Men With Pathologically Involved Lymph Nodes Following Radical Surgery for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  92. RAMEY SJ, Abramowitz MC, Moghanaki D, Agrawal S, et al
    Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  93. AGRAWAL S, Stephenson AJ, Michalski J, Efstathiou JA, et al
    Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  94. KEALL P, Colvill E, Eade T, Juneja P, et al
    Primary and Secondary Outcome Measure Results From the First Prospective Clinical Trial of Electromagnetic-Guided MLC Tracking Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  95. YASMIN-KARIM S, Moreau M, Ngwa W
    In Vitro Study of Small-Sized Nanoparticle-Aided Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  96. GALLAHER IS, Johnson J, Wang X
    Novel Technique Using Full-Dose Low-Dose-Rate Brachytherapy With Field-Matched Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer Improves Rectal Sparing.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  97. ZHANG J, Ates O, Li A
    Implementation of a Machine Learning-Based Automatic Contour Quality Assurance Tool for Online Adaptive Radiation Therapy of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  98. CHRISTIANSEN RL, Jensen HR, Brink C
    Magnetic Resonance-Only Workflow and Validation of Magnetic Resonance-Based Dose Calculations for Radiation Therapy of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  99. STAPOR-FUDZINSKA M, Tarnawski RR, Wydmanski J, Napieralska A, et al
    Doses Delivered to Testes Using Automatic Treatment Plan Optimization for Patients With Low-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  100. LEE S, Kim KH, Cao YJ, Shim JB, et al
    A Study of Acute Genitourinary and Gastrointestinal Toxicity Relationship With Planning Index in Prostate Cancer Treated by Helical Tomotherapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  101. KOIVULA L, Wee L, Korhonen J
    Proton Therapy Treatment Planning With MRI Only: Dose Calculation Accuracy in MRI-Derived Substitute Computed Tomography Images for Brain Tumor and Prostate Cancer Treatments.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  102. WEN N, Bagher-Ebadian H, Pantelic M, Hearshen D, et al
    A Physiologically Nested Pharmacokinetic Model in Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Detection of Dominant Intraprostatic Lesions in Patients With Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  103. BYUN DJ, Happersett L, Zhang P, Pei X, et al
    Variation in Interfractional Bladder Volume during Hypofractionated Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  104. YANG X, Jani A, Rossi PJ, Mao H, et al
    Multiparametric Magnetic Resonance Imaging Guided Radiation Therapy for Prostate Cancer Using Learning-Based Magnetic Resonance Imaging-Computed Tomography Registration.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  105. BALDWIN P, Van De Ven AL, Seitzer N, Clohessy S, et al
    Nanoformulation of the PARP Inhibitor Olaparib Enables Radiosensitization of a Radiation-Resistant Prostate Cancer Model.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  106. MAHMOOD J, Murti SC, Zaveri SR, Shukla HD, et al
    Caveolin-1: A Novel Prognostic Biomarker for Radioresistance in Non-Small Cell Lung Carcinoma (NSCLC) and Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  107. TAUNK NK, Zhang H, Carlin S, Weber W, et al
    Monitoring Prostate Cancer Treatment Response to Radiation Therapy and Androgen Deprivation With Novel Radiolabeled and Dual-Labeled Gastrin-Releasing Peptide Receptor (GRPr) Antagonists.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  108. WIDLAK P, Pietrowska M, Jelonek K, Ros M, et al
    Radiation Therapy-Related Changes in Serum Proteome and Lipidome Are Primarily Associated With a Type of Acute Toxicity: Comparison of Radiation-Induced Effects in Patients Treated Because of Head and Neck Cancer or Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  109. YAMOAH K, Lal P, Mahajan S, Naghavi AO, et al
    Clinical Implications of TMPRSS2-ERG Fusion in African American Men With Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  110. PATEL VL, Busch E, D'Amico AV, Rebbeck TR, et al
    BRCA2 Mutations in Prostate Cancer Assort Into Cluster Regions.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  111. BLANCHARD P, Davis JW, Frank SJ, Jeri K, et al
    How to Counsel Patients With Localized Prostate Cancer About Treatment Selection: Quality-of-Life Results of a Prospective Single-Institution Cohort.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  112. VIGNEAULT E, Savard J, Ivers H, Savard MH, et al
    Validation of a French-Canadian Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  113. BROUGHMAN JR, Basak R, Dickerson GA, Usinger DS, et al
    Comparative Quality of Life Outcomes Among Brachytherapy, Intensity Modulated Radiation Therapy (IMRT), and Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer-Analysis of a Multi-Institutional Prospective Cohort.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  114. AL-HANAQTA MM, Loblaw DA, Chung HT, Cheung P, et al
    Single 19-Gy High-Dose-Rate Brachytherapy Monotherapy for Treatment of Prostate Cancer: Tolerability and Dosimetric Predictors of Acute Toxicity and Health-Related Quality of Life.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  115. SZUMACHER E, Dawdy K, Bonin K, Russell S, et al
    Empowering Patients Through Education-Development and Evaluation of a Multimedia Patient Education Tool to Ensure Patient Preparedness for Planning CT Scan for Prostate Cancer (Randomized Study).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  116. ECHEVARRIA M, Naghavi AO, Abuodeh YA, Chevere CM, et al
    Low-Dose-Rate Brachytherapy for Prostate Cancer in Low Resource Settings.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  117. KOVTUN K, Chen MH, Braccioforte MH, Moran BJ, et al
    Race and the Risk of Death Following High-Dose Radiation Therapy in Men Treated With or Without Androgen Suppression Therapy for Favorable-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  118. FRANK SJ, Pugh TJ, Mahmood U, Blanchard P, et al
    The Value of Brachytherapy for Intermediate-Risk Localized Prostate Cancer Using Ichom Outcomes and Time-Driven Activity-Based Costing: Results From a Phase 2 Prospective Trial of 300 Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  119. MAHAL A, Mahal BA, Singh R, Green AR, et al
    The Effect of Race and Decision Aids on Physician Recommendation for Prostate Cancer Treatment Planning.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  120. KIM HJ, Kim WC
    Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost and Whole-Pelvic Radiation Therapy for Intermediate- and High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  121. FREIBERGER C, Schmitt V, Eble MJ, Pinkawa M, et al
    Prognostic Significance of Rising Prostate-Specific Antigen (PSA) Levels Following Radiation Therapy for Localized Prostate Cancer-Comparison Between PSA Bounce Versus PSA Recurrence.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  122. BOLADERAS A, Ferrer F, Navarro V, De Blas R, et al
    Association Between Dose-Volume Histograms and Health-Related Quality of Life in Patients with Prostate Cancer Treated with External Beam Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  123. HATTORI Y, Nakanishi M, Hashimoto S, Iwata H, et al
    How Did Sexual Function and Serum Testosterone Level Change in Patients With Prostate Cancer After Proton Therapy?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  124. GESTAUT MM, Pruszynski J, Swanson GP
    Prostate Cancer in Patients With High Prostate-Specific Antigen But Otherwise Very Low-Risk Disease Behaves Like Prostate Cancer in High-Risk Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  125. WANG J, Zhao D, Veruttipong D, Kupelian PA, et al
    Combined Pretreatment Serum Testosterone Concentration and Risk Stratification Enhances Interpretation of Prostate-Specific Antigen (PSA) Kinetics in Localized Prostate Cancer After Stereotactic Body Radiation Therapy (SBRT).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  126. SHAO M, Osborn V, Lederman AJ, Lee A, et al
    Impact of Current or Prior Smoking Use for Men Receiving External Beam Radiation for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  127. ARORA D, Schurr R, Zhang F, Gestaut MM, et al
    The Effect of Comprehensive Pelvic Nodal Radiation in Prostate Cancer on the CBC.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  128. FINKELSTEIN SE, Forman J, Fernandez E, Chen CT, et al
    Multicenter Assessment of Stereotactic Body Radiation Therapy (SBRT) Boost in Intermediate-Risk Prostate Cancer: Biochemical Failure and Toxicity.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  129. SCOBIOALA S, Kittel C, Haverkamp U, Channaoui M, et al
    A Dosimetric Comparison Between Conventionally Fractionated Tomotherapy, Volumetric Modulated Arc Therapy, Sliding Window and Proton Therapy, and Hypofractionated Robotic Radiosurgery Treatment by Low-Risk Prostate Carcinoma.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  130. ZAORSKY NG, Handorf E, Horwitz EM, Hallman MA, et al
    Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  131. FAGUNDES MA, Price SG, Robison B, Case S, et al
    Evolving Rectal Sparing in Fiducial-Based Image Guided Proton Therapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  132. AVUZZI B, Cozzarini C, Rancati T, Improta I, et al
    What Happens to Testosterone Levels After Radical Radiation Therapy for Prostate Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  133. FISCHER-VALUCK BW, Gay HA, Michalski J
    Magnetic Resonance Image Guided Radiation Therapy (MR-IGRT) for the Treatment of Prostate Cancer: Initial Clinical Experience and Patient Selection.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  134. GALALAE R, Schroeder C, Geiger F, Siebert FA, et al
    Superiority of Real-Time Adaptive Interstitial High-Dose-Rate Brachytherapy for Localized Prostate Cancer-Five- and 8-Year Outcomes of Kiel University Hospital Protocols.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  135. CASCALES GARCIA MA, Colmenero M, Rodriguez Antolin A, Samper Ots PM, et al
    Measuring Quality of Life in Low-Risk Prostate Cancer Treated With Surgery, External Beam Radiation Therapy, or Brachytherapy. CAPCIRAB Project: A Prospective, Multicentric Cohort Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  136. TAKEMOTO S, Shibamoto Y, Sugie C, Manabe Y, et al
    Long-Term Results of Intensity Modulated Radiation Therapy With 3 Dose-Fractionation Regimens for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  137. KIM HJ, Kim WC
    Prostate-Specific Antigen Kinetics After Hypofractionated Stereotactic Body Radiation Therapy Boost as Post-External Beam Radiation Therapy (EBRT) Versus Conventionally Fractionated EBRT for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  138. LEVINE R, Russo S, Su LM, Stringer T, et al
    An Evaluation the Implementation of Evidence-Based Quality Improvement Metrics for Prostate Cancer Management in a Multidisciplinary Tertiary Care Setting.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  139. NAKAMURA K, Mizowaki T, Inokuchi H, Ikeda I, et al
    A Pilot Study of Hypofractionated Intensity Modulated Radiation Therapy Over 3 Weeks for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  140. NICHOLS RC, Morris CG, Bryant CM, Hoppe BS, et al
    Changes in Serum Testosterone 60 Months After Proton Therapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  141. FISCHER-VALUCK BW, Mazur TR, Gay HA, Olsen LA, et al
    A Treatment Planning Comparison of Proton Therapy and Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer Using the Normal Tissue Complication Probability (NTCP).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  142. TSVANG L, Dubouloz A, Alezra D, Symon Z, et al
    Meeting Dose Objectives in Stereotactic Body Radiation Therapy for Prostate Cancer: Water- Versus Air-Filled Endorectal Balloon?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  143. WOJCIESZEK PA, Szlag M, Glowacki G, Cholewka A, et al
    Intermediate-Risk Prostate Cancer Treated With 3 Radioablative Regimens: Comparison of Robotic Ultrahypofractionation and High-Dose-Rate Brachytherapy Alone or Combined With External Beam Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  144. SAMLALI H, Udrescu C, Enachescu C, Yossi S, et al
    Prospective Evaluation of a Specific Technique of Sexual Function Preservation in External Beam Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  145. QI X, Gao XS, Li H, Qin SB, et al
    Initial Outcome of Definitive Intensity Modulated Radiation Therapy in Treatment of Bone Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  146. YE H, Blas KG, Yan D, Brabbins DS, et al
    A Matched Comparison of Patients Treated With Standard Dose External Beam Radiation Versus Dose-Escalated, Adaptive, Image Guided External Beam Radiation for Favorable Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  147. GOFF PH, Harrison LB, Furhang EE, Trichter F, et al
    Fiducial Marker-Based 2-Dimensional kV Orthogonal Imaging Is More Reliable for Adjusting Interfractional Shifts Than Soft Tissue-Based Cone Beam Computed Tomography for Image Guided IMRT for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  148. SOAIDA SM, Mulla Z, El Sayed ME, Soliman OY, et al
    Image Guided Radiation Therapy Treatment Using Daily Versus Weekly Cone Beam Computed Tomography for Intensity Modulated Radiation Therapy of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  149. JOSEPH N, Rancati T, Cicchetti A, Valdagni R, et al
    A Higher Whole-Pelvic Integral Dose Is Associated With Worsening Fatigue and Functional Outcome in Prostate Cancer Patients Treated With Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  150. LEE HS, Park W, Pyo HR, Kim CK, et al
    The Clinical Impact of Tumor Response on Magnetic Resonance Imaging After Salvage Radiation Therapy for Locally Recurrent Prostate Cancer After Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  151. GREER MD, Valle L, Madan RA, Krauze AV, et al
    Magnetic Resonance Imaging Findings Associated With Urinary Symptoms After Intensity Modulated Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  152. MALOUFF T, Walters RW, Marsh S, Silberstein P, et al
    Comparison of External Beam Radiation Therapy (EBRT) Techniques on Survival in Stage IIA Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  153. BAYDOUN A, Traughber B, Morris N, McGraw M, et al
    Outcomes and Toxicities in Patients Treated With Definitive Focal Therapy for Primary Prostate Cancer: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  154. HENKENBERENS C, Bengel F, Wester HJ, Christiansen H, et al
    Early Efficacy of68ga-PSMA Ligand Positron Emission Tomography/Computed Tomography-Based Radiation Treatment in Locally Recurrent and Oligometastatic Prostate Cancer After Primary Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  155. OKAZAKI E, Ishii K, Hosono M, Ogino R, et al
    Postimplant Segmental Dosimetry, Biochemical Relapse, and Toxicity in Patients With Prostate Cancer Treated With Loose Iodine-125 Seeds.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  156. MALOUFF T, Marsh S, Walters RW, Silberstein P, et al
    Long-Term Survival by Method of Brachytherapy in Stage IIA Prostate Cancer: A National Cancer Data Base (NCDB) Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  157. ZHU S, Syed J, Holtzman AL, Morris CG, et al
    Primary Radiation Therapy for Prostate Cancer in Men Younger Than 60 Years of Age.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  158. WANG W, Gao XS, Xiong W, Li XY, et al
    The Effect and Mechanism of 2'-Hydroxyflavanone's Impact on the Radiosensitization of Prostate Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  159. SZUMACHER E, Bristow B, Aldehaim M, Bonin K, et al
    Patterns of Care Among Canadian Radiation Oncologists and Urologists Related to Postoperative Radiation Therapy for Patients With Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  160. FERRER F, Pont A, Letelier HA, Garin O, et al
    Early Experience and Quality of Life Comparison in Prostate Cancer Brachytherapy Versus Phase I-II Stereotactic Body Radiation Therapy Trials.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  161. TAKAGI M, Demizu Y, Fuwa N, Sulaiman NS, et al
    Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  162. ANSCHER MS, Chang MG, Moghanaki D, Rosu M, et al
    The Effect of Lovastatin on Preservation of Erectile Function After Radiation Therapy (RT) for Prostate Cancer: Secondary Analysis of a Prospective Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  163. CHEN L, Cvetkovic D, Wang B, Gupta R, et al
    Management of Prostate Cancer Using Magnetic Resonance Guided Pulsed Focused Ultrasound-Mediated Targeted Chemotherapeutic Agent Delivery.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  164. BANG A, Malone S, Leung EY, Canil C, et al
    Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Single-Institution Analysis of Factors Associated With Treatment Completion and Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  165. LU SM, Cosmatos H, Finley DS, Kim DW, et al
    Predictors of Biochemical Control Following Salvage Cryotherapy for Radiorecurrent Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  166. DIBIASE SJ, Srivastav S
    The Influence of Treatment Energy on Cardiac Devices in Patients Undergoing Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  167. WANG EH, Abouassaly R, Yu JB, Meropol NJ, et al
    Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  168. RANCATI T, Improta I, Palorini F, Cozzarini C, et al
    Local Dose Descriptors Correlated With Late Urinary Toxicity at 6 to 24 Months After Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  169. FOLEY K, Groome P, Feldman-Stewart D, Brundage M, et al
    Measuring the Quality of Personal Care in Patients Undergoing Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  170. BOYER MJ, Rushing C, Peterson B, Papagikos MA, et al
    Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  171. MURALIDHAR V, Nezolosky MD, Chen YW, Martin NE, et al
    Adverse Pathologic Features Following Prostatectomy for Favorable High-Risk Versus Other High-Risk Prostate Cancer: Implications for Choice of Local Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  172. ANDERSON E, Wong WW, Mohammadi H, Daniels TB, et al
    Predictors for Survival After Radium-223 Treatment for Castration-Resistant Metastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  173. LIU J, Sasamoto R, Kaidu M, Ayukawa F, et al
    High-Dose-Rate Brachytherapy in Which 2 Fractions Were Administered Within a Single Day Combined With External Beam Radiation Therapy for Prostate Cancer: Four-year Experience and Outcomes.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  174. LAUCHE O, Delouya G, Taussky D, Beliveau-Nadeau D, et al
    Single-Fraction High-Dose-Rate Brachytherapy Using Real-Time Transrectal Ultrasound-Based Planning in Combination With External Beam Radiation Therapy for Prostate Cancer: Dosimetrics and Early Clinical Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  175. ZAMBOGLOU C, Schiller F, Fechter T, Drendel V, et al
    A Voxel-Wise Comparison of68ga-Hbed-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: Implementations for Radiation Therapy Treatment Planning.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  176. GU X, Gao X
    Association Between IL-6 -174G>C Polymorphism and Risk of Prostate Cancer: A Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  177. GUNNLAUGSSON A, Kjellen E, Blom R, Bratt O, et al
    Prospective Prediction Model Using Prostate-Specific Antigen During Salvage Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  178. DEN RB, Davicioni E, Takhar M, Erho NG, et al
    The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  179. KATZ A, Kang J
    Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  180. GOMEZ-ITURRIAGA A, Casquero F, Fernandez I, Rodeno E, et al
    Outcomes After a First and/or Second Salvage Treatment in Patients With Oligometastatic Prostate Cancer Recurrence Detected by (18-F) Choline Positron Emission Tomography/Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  181. FERRER F, Ballon K, Boladeras A, De Blas R, et al
    Pelvic Volumetric Modulated Arc Therapy (VMAT) for Prostate for Locally Advanced Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  182. TRAN PT, Radwan N, Ross AE, Reyes D, et al
    Stereotactic Ablative Radiation Therapy for the Treatment of Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  183. WANG C, Wang J, Pennington JD, Kupelian PA, et al
    Racial Disparities in Prostate Cancer-Specific Survival After Definitive Treatment for Gleason 8-10 Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  184. CVEK J, Knybel L, Skacelikova E, Otahal B, et al
    Ultrahypofractionated Stereotactic Radiation Therapy for Low-Intermediate Stage Prostate Cancer-Results From a Single Institution.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  185. WONG AT, Schwartz D, Lee A, Safdieh J, et al
    Patterns of Postprostatectomy Adjuvant Radiation Therapy Utilization for Nonmetastatic Prostate Cancer in a Large, National Cohort.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  186. DOUCETTE C, Grossman CE, Messing E, Joseph J, et al
    High Incidence of Pathologic Upgrading and Upstaging in Clinically Unfavorable Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  187. AMINI A, Kavanagh BD, Raben D, Crawford ED, et al
    Proton Beam Therapy Utilization and Disparity in the United States for Treatment of Localized Prostate Cancer: A Study of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  188. STEPHANS KL, Thousand R, Reddy CA, Magnelli A, et al
    Heterogeneous Dose-Escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: An Institutional Phase 2 Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  189. KAWAMURA H, Murata K, Takakusagi Y, Okonogi N, et al
    Simultaneous Integrated Boost Intensity Modulated Radiation Therapy for Clinically Node-Positive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  190. JOHNSON SB, Soulos PR, Shafman TD, Mantz CA, et al
    Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  191. SAFDIEH J, Schwartz D, Osborn V, Wong AT, et al
    Utilization of Prostate Brachytherapy for Low-Risk Prostate Cancer: Is the Decline Overstated?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  192. MURALIDHAR V, Nezolosky MD, Chen YW, Martin NE, et al
    National Trends in Androgen Deprivation Therapy Use for Prostate Cancer After Versus Before the Controversy Surrounding Cardiovascular Toxicity.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  193. ZAPATERO A, Roch M, Buchser D, Castro P, et al
    Improved Late Rectal and Urinary Toxicity With High-Dose Intensity Modulated Radiation Therapy Using Intraprostate Fiducial Markers for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  194. WANG WG, Yan D, Ye H, Gustafson GS, et al
    Outcomes and Toxicity From a Prospective Study of Moderate Hypofractionated Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  195. JOHNSON SB, Lester-Coll NH, Stahl JM, Nath SK, et al
    Impact of Concurrent Androgen-Deprivation Therapy and Radiation Therapy Versus Radiation Therapy Alone on Overall Survival for Men With Unfavorable Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  196. CHOI S, Levy LB, Lee KK, Nguyen QN, et al
    Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  197. CHAN J, Rowntree T, Brunt JN, Howard L, et al
    Hypofractionated Dose Painting Intensity Modulated Radiation Therapy for Intermediate- to High-Risk Localized Prostate Cancer: Treatment With 20 Fractions.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  198. TUMATI V, Spratt DE, Jackson WC, Feng FY, et al
    Natural History of Progression After Biochemical Failure Following Postoperative Radiation Therapy in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  199. SHAVERDIAN N, Demanes J, Veruttipong D, Wang J, et al
    Exploring Value From the Patient's Perspective Between Stereotactic Body Radiation Therapy, Intensity Modulated Radiation Therapy, and High-Dose-Rate Brachytherapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  200. ALEXIDIS P, Christodouleas JP, Bekelman JE, Vapiwala N, et al
    The Use of High- and Very-High-Dose Radiation in the Postoperative Treatment of Prostate Cancer in the United States Between 2003 and 2012.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  201. WELLER MA, Kittel J, Reddy CA, Klein EA, et al
    Long-Term Toxicity Comparison Between Brachytherapy and Radical Prostatectomy in High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  202. HEGDE JV, Wang J, Margolis D, Huang J, et al
    Establishing Predictors of Satellite Lesions in Men With Intermediate- and High-Risk Prostate Cancer for Improved Patient Selection for Focal and Focused Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  203. STISH BJ, Pisansky TM, Harmsen WS, Davis BJ, et al
    Early Salvage Radiation Therapy Is Associated With Improved Metastasis-Free, Prostate Cancer-Specific and Overall Survival in Men With Detectable PSA Following Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  204. STOCK RG, Sfakianos J, Oh W, Stone NN, et al
    Prostate-Specific Antigen Doubling Time Posttreatment Is the Most Significant Predictor of Survival Following the Brachytherapy Management of Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  205. SCHILD M, Wong WW, Schild SE, Vora S, et al
    A Prospective Trial of Intensity Modulated Radiation Therapy Incorporating a 111-Indium-Capromab Pendetide Guided Boost for Prostate Cancer: Ten-Year Outcomes.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  206. SINHA S, Muralidhar V, Nguyen PL
    Characteristics and National Trends of Patients Receiving Prostate or Pelvic Radiation for Metastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  207. MALOUFF T, Marsh S, Walters RW, Silberstein P, et al
    Trends in the Use of Radiation Therapy for Stage IIA Prostate Cancer From 2004 to 2013: A Retrospective Analysis Using the National Cancer Data Base (NCDB).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  208. FREDMAN ET, Tabayoyong W, Ponsky L, Abouassaly R, et al
    Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer-A Single-Institution Initial Analysis of Toxicity.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  209. BECK R, Green WR, Kim S, Motwani SB, et al
    Geography and Insurance Status: Underestimated Factors Influencing Treatment Decisions in Intermediate- and High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  210. MOGHANAKI D, Harris E, Urdaneta AI, Williams M, et al
    Multiparametric Magnetic Resonance Imaging Guided Salvage Low-Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer-A 15-Year Experience.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  211. BROWN AM, Sankineni S, Cieciera M, Mertan FV, et al
    Semiautomated Prostate Cancer Segmentation on High b-Value Diffusion-Weighted Magnetic Resonance Imaging Predicts Whole Mount Histopathology.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  212. WANG C, Iwamoto K, Wang J, Low D, et al
    Trends in Radiation-Induced Second Malignancy With Increased Utilization of Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  213. KISHAN AU, Wang J, Rwigema JC, Saigal C, et al
    Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer: Results of an International Patterns of Care Survey.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  214. RAZIEE H, Murgic J, Pintilie M, Chung P, et al
    Assessment of Biochemical Outcomes with Increasing Dose Escalation in Localized Prostate Cancer (PCa) Treated with Precision Image Guided Radiation Therapy (IGRT).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  215. QI X, Wang J, Gomez CL, Xu X, et al
    Patient-Reported Outcome After Prostate Stereotactic Body Radiation Therapy-An Analysis of Dosimetric Correlation of Minimally Import Difference for the Expanded Prostate Cancer Index Composite Short Form (EIPIC-26).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  216. DESS RT, Jackson WC, Hamstra DA, Suy S, et al
    Prospective Patient-Reported Outcomes After Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer: Longitudinal Predictors of Potency Preservation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  217. SANFORD NN, Chen MH, Loffredo M, Renshaw A, et al
    Duration of the Anti-Androgen in Men Undergoing 6 Months of an LHRH Agonist and Radiation Therapy for Unfavorable-Risk Prostate Cancer and the Risk of Death.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  218. SPRATT DE, Osborne J, Zumsteg ZS, Rebiez K, et al
    Radium-223 Outcomes After Multiple Lines of Metastatic Castration-Resistant Prostate Cancer Therapy in Clinical Practice: Implication of Pretreatment Spinal Epidural Disease.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  219. OLARTE A, Gomez-Iturriaga A, Fernandez I, Casquero F, et al
    Salvage Treatment in Patients With Prostate Cancer Oligorecurrence: Impact of 18-F-Fluorocholine Positron Emission Tomography/Computed Tomography on Clinical Decision Making.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  220. CHINEA FM, Patel V, Lamichhane N, Kwon D, et al
    Exploring Heterogeneity Within Hispanic/Latino Men Diagnosed With Prostate Cancer to Identify at-Risk US Populations.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  221. MOON DH, Basak RS, Chen RC
    Patterns of Care of Node-Positive Prostate Cancer Patients Across the United States.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  222. ZUMSTEG ZS, Spratt DE, Pei X, Zhang Z, et al
    Redefining Unfavorable Risk Prostate Cancer: A Novel Risk Stratification Paradigm for Enhanced Outcome Prediction Via Harmonization and Unification of Risk Stratification Criteria.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


    September 2016
  223. PISANSKY TM, Agrawal S, Hamstra DA, Koontz BF, et al
    Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
    Int J Radiat Oncol Biol Phys. 2016 Sep 3. pii: S0360-3016(16)33158.
    PubMed     Text format     Abstract available


    August 2016

  224. Erratum to: Nguyen PL. Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2016;94:975-977.
    Int J Radiat Oncol Biol Phys. 2016;95:1549.
    PubMed     Text format    


    July 2016
  225. ZIETMAN AL, Smith J, Klein E, Droller M, et al
    Editorial Statement on Gleason Scoring for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:1092.
    PubMed     Text format    


  226. KOTECHA R, Djemil T, Tendulkar RD, Reddy CA, et al
    Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2016;95:960-4.
    PubMed     Text format     Abstract available


    June 2016
  227. MULDERMANS JL, Romak LB, Kwon ED, Park SS, et al
    Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:696-702.
    PubMed     Text format     Abstract available


    May 2016
  228. ZILLI T, Benz E, Dipasquale G, Rouzaud M, et al
    Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.
    Int J Radiat Oncol Biol Phys. 2016 May 28. pii: S0360-3016(16)30280.
    PubMed     Text format     Abstract available


  229. MURALIDHAR V, Rose BS, Chen YW, Nezolosky MD, et al
    Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
    Int J Radiat Oncol Biol Phys. 2016 May 27. pii: S0360-3016(16)30278.
    PubMed     Text format     Abstract available


  230. DELL'OGLIO P, Boehm K, Trudeau V, Tian Z, et al
    Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016 May 10. pii: S0360-3016(16)30196.
    PubMed     Text format     Abstract available


  231. HABL G, Uhl M, Katayama S, Kessel KA, et al
    Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study-The IPI Trial.
    Int J Radiat Oncol Biol Phys. 2016;95:435-43.
    PubMed     Text format     Abstract available


  232. BRYANT C, Smith TL, Henderson RH, Hoppe BS, et al
    Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:422-34.
    PubMed     Text format     Abstract available


  233. UNDERWOOD T, Giantsoudi D, Moteabbed M, Zietman A, et al
    Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:454-64.
    PubMed     Text format     Abstract available


  234. ARIMURA T, Ogino T, Yoshiura T, Toi Y, et al
    Effect of Film Dressing on Acute Radiation Dermatitis Secondary to Proton Beam Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:472-6.
    PubMed     Text format     Abstract available


  235. GAMEIRO SR, Malamas AS, Bernstein MB, Tsang KY, et al
    Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.
    Int J Radiat Oncol Biol Phys. 2016;95:120-30.
    PubMed     Text format     Abstract available


    April 2016
  236. GIBSON E, Bauman GS, Romagnoli C, Cool DW, et al
    Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
    Int J Radiat Oncol Biol Phys. 2016 Apr 21. pii: S0360-3016(16)30121.
    PubMed     Text format     Abstract available


  237. MUSUNURU HB, Davidson M, Cheung P, Vesprini D, et al
    Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:1043-51.
    PubMed     Text format     Abstract available


  238. KEALL PJ, Ng JA, Juneja P, O'Brien RT, et al
    Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring-Guided Gating for Prostate Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;94:1015-21.
    PubMed     Text format     Abstract available


  239. NGUYEN PL
    Rethinking the Balance of Risk and Benefit of Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:975-7.
    PubMed     Text format    


    March 2016
  240. CHEN YW, Mahal BA, Muralidhar V, Nezolosky M, et al
    Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:683-90.
    PubMed     Text format     Abstract available


  241. NGUYEN PL, Ciezki JP
    High-Dose-Rate Monotherapy for Localized Prostate Cancer-What More Will It Take to Make This a Standard Therapy?
    Int J Radiat Oncol Biol Phys. 2016;94:655-6.
    PubMed     Text format    


  242. LEWIS SL, Patel PR, Palta M, Yoo DS, et al
    In Reply to Fiorino and Cozzarini.
    Int J Radiat Oncol Biol Phys. 2016;94:860-1.
    PubMed     Text format    


  243. FIORINO C, Cozzarini C
    In Regard to Lewis et al.
    Int J Radiat Oncol Biol Phys. 2016;94:859-60.
    PubMed     Text format    


  244. NABAVIZADEH N, Elliott DA, Chen Y, Kusano AS, et al
    Image Guided Radiation Therapy (IGRT) Practice Patterns and IGRT's Impact on Workflow and Treatment Planning: Results From a National Survey of American Society for Radiation Oncology Members.
    Int J Radiat Oncol Biol Phys. 2016;94:850-7.
    PubMed     Text format     Abstract available


  245. HUYNH MA, Chen MH, Wu J, Braccioforte MH, et al
    Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone.
    Int J Radiat Oncol Biol Phys. 2016 Mar 11. pii: S0360-3016(16)00295.
    PubMed     Text format     Abstract available


  246. SLAGSVOLD JE, Viset T, Wibe A, Kaasa S, et al
    Radiation Therapy Did Not Induce Long-Term Changes in Rectal Mucosa: Results From the Randomized Scandinavian Prostate Cancer Group-7 Trial.
    Int J Radiat Oncol Biol Phys. 2016 Mar 3. pii: S0360-3016(16)00221.
    PubMed     Text format     Abstract available


  247. LEWIS SL, Patel P, Song H, Freedland SJ, et al
    Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:605-11.
    PubMed     Text format     Abstract available


    February 2016
  248. MOLINA S, Guerif S, Garcia A, Debiais C, et al
    DNA-PKcs Expression Is a Predictor of Biochemical Recurrence After Permanent Iodine 125 Interstitial Brachytherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Feb 11. pii: S0360-3016(16)00129.
    PubMed     Text format     Abstract available


  249. BOSSART EL, Stoyanova R, Sandler K, Studenski M, et al
    Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Feb 4. pii: S0360-3016(16)00105.
    PubMed     Text format     Abstract available


  250. FOLEY KA, Feldman-Stewart D, Groome PA, Brundage MD, et al
    What Aspects of Personal Care Are Most Important to Patients Undergoing Radiation Therapy for Prostate Cancer?
    Int J Radiat Oncol Biol Phys. 2016;94:280-8.
    PubMed     Text format     Abstract available


  251. KOUNTOURI M, Zilli T, Rouzaud M, Dubouloz A, et al
    Moderate Hypofractionated Protracted Radiation Therapy and Dose Escalation for Prostate Cancer: Do Dose and Overall Treatment Time Matter?
    Int J Radiat Oncol Biol Phys. 2016;94:272-9.
    PubMed     Text format     Abstract available


  252. MULLER AC, Eckert F, Paulsen F, Zips D, et al
    Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:263-71.
    PubMed     Text format     Abstract available


  253. NARANG AK, Gergis C, Robertson SP, He P, et al
    Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.
    Int J Radiat Oncol Biol Phys. 2016;94:254-62.
    PubMed     Text format     Abstract available


    January 2016
  254. WORTEL RC, Incrocci L, Pos FJ, van der Heide UA, et al
    Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts.
    Int J Radiat Oncol Biol Phys. 2016 Jan 22. pii: S0360-3016(16)00052.
    PubMed     Text format     Abstract available


  255. ALASHKHAM A, Paterson C, Rauchhaus P, Nabi G, et al
    Can Angiotensin-Converting Enzyme Inhibitors Reduce the Incidence, Severity, and Duration of Radiation Proctitis?
    Int J Radiat Oncol Biol Phys. 2016;94:93-101.
    PubMed     Text format     Abstract available


    December 2015
  256. MOTEABBED M, Trofimov A, Sharp GC, Wang Y, et al
    A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2015 Dec 29. pii: S0360-3016(15)27220.
    PubMed     Text format     Abstract available


  257. HOLTZMAN AL, Hoppe BS, Letter HP, Bryant C, et al
    Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.
    Int J Radiat Oncol Biol Phys. 2015 Dec 19. pii: S0360-3016(15)27189.
    PubMed     Text format     Abstract available


  258. ROACH M 3RD, Ceron Lizarraga TL, Lazar AA
    Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?
    Int J Radiat Oncol Biol Phys. 2015;93:1064-1070.
    PubMed     Text format     Abstract available


  259. AMINI A, Jones BL, Yeh N, Rusthoven CG, et al
    Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2015;93:1052-1063.
    PubMed     Text format     Abstract available


  260. BAUMAN G, Rodrigues G, Chen J, Loblaw A, et al
    In Reply to Kishan et al.
    Int J Radiat Oncol Biol Phys. 2015;93:1163.
    PubMed     Text format    


  261. KISHAN AU, Steinberg ML, Kupelian PA, King CR, et al
    In Regard to Bauman et al.
    Int J Radiat Oncol Biol Phys. 2015;93:1162-3.
    PubMed     Text format    


  262. DOWLING JA, Sun J, Pichler P, Rivest-Henault D, et al
    Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
    Int J Radiat Oncol Biol Phys. 2015;93:1144-53.
    PubMed     Text format     Abstract available


  263. TRADA Y, Kneebone A, Paneghel A, Pearse M, et al
    Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
    Int J Radiat Oncol Biol Phys. 2015;93:1045-51.
    PubMed     Text format     Abstract available


    November 2015
  264. MARIADOS N, Hamstra DA
    In Reply to King et al.
    Int J Radiat Oncol Biol Phys. 2015;93:937-9.
    PubMed     Text format    


  265. KING CR, Kamrava M, Wang PC, Steinberg ML, et al
    In Regard to Mariados et al.
    Int J Radiat Oncol Biol Phys. 2015;93:936-7.
    PubMed     Text format    


  266. MCDONALD R, Probyn L, Poon I, Erler D, et al
    Tumor Response After Stereotactic Body Radiation Therapy to Nonspine Bone Metastases: An Evaluation of Response Criteria.
    Int J Radiat Oncol Biol Phys. 2015;93:879-81.
    PubMed     Text format     Abstract available


  267. YAMOAH K, Showalter TN, Ohri N
    Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials.
    Int J Radiat Oncol Biol Phys. 2015;93:737-45.
    PubMed     Text format     Abstract available


  268. JAWAD MS, Dilworth JT, Gustafson GS, Ye H, et al
    Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2015 Nov 10. pii: S0360-3016(15)26576.
    PubMed     Text format     Abstract available


  269. BHATTACHARYYA T, Purushothaman K, Puthiyottil SS, Muttath G, et al
    External Beam Radiation Therapy and Abiraterone in Men With Localized Prostate Cancer: Safety and Effect on Tissue Androgens. In Regard to Cho et al.
    Int J Radiat Oncol Biol Phys. 2015;93:719.
    PubMed     Text format    


  270. CHO E, Mostaghel EA, Russell KJ, Liao JJ, et al
    In Reply to Bhattacharyya et al.
    Int J Radiat Oncol Biol Phys. 2015;93:719-20.
    PubMed     Text format    


  271. WOODRUFF HC, Fuangrod T, Van Uytven E, McCurdy BM, et al
    First Experience With Real-Time EPID-Based Delivery Verification During IMRT and VMAT Sessions.
    Int J Radiat Oncol Biol Phys. 2015;93:516-22.
    PubMed     Text format     Abstract available


  272. WESTHOFF PG, de Graeff A, Monninkhof EM, Pomp J, et al
    Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2015;93:694-701.
    PubMed     Text format     Abstract available


    October 2015
  273. KUANG Y, Wu L, Hirata E, Miyazaki K, et al
    In Reply to von Eyben et al.
    Int J Radiat Oncol Biol Phys. 2015;93:467-8.
    PubMed     Text format    


  274. VON EYBEN FE, Kiljunen T, Kangasmaki A, Kairemo K, et al
    Volumetric Modulated Arc Therapy Planning For Primary Prostate Cancer With Selective Intraprostatic Boost Determined By (18) f-Choline PET-CT: In Regard to Kuang et al.
    Int J Radiat Oncol Biol Phys. 2015;93:466-7.
    PubMed     Text format    


  275. ALAM A, Mukhopadhyay ND, Ning Y, Reshko LB, et al
    A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFbeta1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.
    Int J Radiat Oncol Biol Phys. 2015;93:436-43.
    PubMed     Text format     Abstract available


    September 2015
  276. BLANCHARD P, Faivre L, Lesaunier F, Salem N, et al
    Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2015 Sep 25. pii: S0360-3016(15)26476.
    PubMed     Text format     Abstract available


    August 2015
  277. GRANT SR, Walker GV, Koshy M, Shaitelman SF, et al
    Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2015 Aug 28. pii: S0360-3016(15)03193.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: